Last reviewed · How we verify
NCT06589336: SUSTAIN
SUSTAIN: Behavior Change and Nutrition Security for CKMS
NA trial testing Dietary changes via Instacart vouchers in Stage 2 Cardiovascular-Kidney-Metabolic Syndrome in 106 participants. Completed in 29 August 2025.
29 August 2025
Quick facts
| Lead sponsor | Ohio State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 106 |
| Start date | 26 August 2024 |
| Primary completion | 29 August 2025 |
| Estimated completion | 29 August 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Dietary changes via Instacart vouchers
- Dietary changes via access to Mid-Ohio Farmacy
- Behavior changes via access to Health Impact Ohio Hub
- Behavioral nutrition counseling
- Cooking classes
- Dietary changes to Delivery fees
Conditions studied
- Stage 2 Cardiovascular-Kidney-Metabolic Syndrome — all drugs for Stage 2 Cardiovascular-Kidney-Metabolic Syndrome →
- Cardiovascular Disease Other — all drugs for Cardiovascular Disease Other →
Sponsor
Ohio State University
Who can join
18 and older, any sex, with Stage 2 Cardiovascular-Kidney-Metabolic Syndrome or Cardiovascular Disease Other. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine the feasibility and engagement of participants in the SUSTAIN intervention compared to enhanced usual care over 24 weeks through mixed-methods measurement of participant enrollment, adherence, retention, and engagement (counseling, screenings, referrals, and uptake). Methods: Leveraging rigorous quantitative and qualitative evaluation, the study team will identify mechanisms driving intervention feasibility and engagement. Hypothesis: SUSTAIN will be feasible with a high degree of engagement among Medicaid-enrolled participants with Stage 2 CKMS in comparison to enhanced usual care.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Promoting sustained behavior change and nutrition security in medicaid-enrolled individuals with stage 2 cardiovascular kidney metabolic syndrome (CKMS): Protocol of the SUSTAIN study.
Walker DM, Spees C, Brock G, Williams A, et al · · 2026 · PMID 41819445 · DOI 10.1016/j.cct.2026.108285
Verify or expand the search:
- PubMed search for NCT06589336
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Ohio State University trials
Trials by the same sponsor.
- NCT06542458 — Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog · not yet recruiting
- NCT07217548 — Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease Patients · NA · enrolling by invitation
- NCT07215221 — Implementation of TBI-RECOVER in Substance Use Treatment · NA · not yet recruiting
- NCT07278427 — Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START · recruiting
- NCT07490444 — Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06589336 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ohio State University
- Last refreshed: 11 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06589336.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing